Bioactive peptides SL-13R and KS-13 enhance human adipose-derived mesenchymal stem cell proliferation in vitro
DOI:
https://doi.org/10.3329/bjp.v19i2.72739Keywords:
AD-MSC expansion, Bioactive peptide, KS-13, Mesenchymal stem cell, SL-13RAbstract
No abstract
Downloads
137
138
References
Akbarian M, Khani A, Eghbalpour S, Uversky VN. Bioactive peptides: Synthesis, sources, applications, and proposed mechanisms of Action. Int J Mol Sci. 2022; 23: 1445.
Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS, Schultz PG, Cooke MP. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010; 329: 1345-48.
Dayem AA, Lee SB, Lim KM, Kim A, Shin HJ, Vellingiri B, Kim YB, Cho SG. Bioactive peptides for boosting stem cell culture platform: Methods and applications. Biomed Pharmacother. 2023; 160: 114376.
Han H, Jayaraman A, Safe S, Chapkin RS. Targeting the aryl hydrocarbon receptor in stem cells to improve the use of food as medicine. Curr Stem Cell Rep. 2020; 6: 109-18.
Han YS, Yun SP, Ko HS, Lee SH. Therapeutic effect of genistein-stimulated human mesenchymal stem cells in myocardial infarction. J Transplant Stem Cel Biol. 2014; 1: 7.
Kim D. Method for culturing adiposed derived stem cell. 2013: Patent Numbers: 10-1624514, 10-1643315, 10-1590416.
Nguyen NT, Hanieh H, Nakahama T, Kishimoto T. The roles of aryl hydrocarbon receptor in immune responses. Int Immunol. 2013; 25: 335–43.
Nii T, Konno K, Matsumoto M, Bhukhai K, Borwornpinyo S, Sakai K, Hongeng S, Sugiyama D. The bioactive peptide SL-13R expands human umbilical cord blood hematopoietic stem and progenitor cells in vitro. Molecules 2021; 26: 1995.
Tran MD, Tran T, Nguyen N, Chu H, Nakahama T, Nguyen N. Anti-inflammatory activity of 9-hydroxycanthin-6-one extracted from hairy-root cultures of Eurycoma longifolia potentially via aryl hydrocarbon receptor induction. Bangladesh J Pharmacol. 2022; 17: 102-04.
Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, Wang X, Wang R, Fu C. Therapeutic peptides: current applications and future directions. Sig Transduct Target Ther. 2022; 7: 48.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Thanh Trung Tran, Kien Trung Tran, Daeyong Kim, Nam Trung Nguyen
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).